Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove


Large Animal Models of Cardiovascular Disease: From Training to Translation

Published: March 3, 2023 doi: 10.3791/64983


Cardiovascular diseases (CVDs) represent the main cause of morbidity and mortality worldwide1. Consequently, research in this field is required. While somewhat controversial, especially if not done right, the use of animals for research and training purposes remains a mandatory step of translational research. Small animal models have contributed considerably to unraveling the cellular and molecular mechanisms of CVDs, but extrapolation to a clinical scenario is hindered by the remarkable cardiovascular dissimilarities with humans2,3. Hence there is importance in large animal models, as they are closer to humans with respect to size as well as anatomical and physiological features3,4.

While experimental models cannot fully resemble the clinical condition, this methods collection aims to help researchers choose the large animal model that best represents the disease being investigated to allow researchers the ability to test novel procedures and devices in systems that recreate the human anatomy, while prioritizing animal welfare. These animal models also intend to help medical professionals learn and practice challenging procedures in human-like systems using clinical-grade equipment and surgical techniques4.

Cerebrovascular disease involves a series of conditions, including intracranial aneurysms (IA) that present a high mortality rate in case of rupture. The development of new tools or therapeutic strategies for the management of IA must be explored in a preclinical setting before translation to a clinical scenario can be performed. Blanco-Blázquez et al. describe two surgically created aneurysmal swine models that show encouraging results in the research field of nonruptured aneurysms and training in neuroradiology techniques5. Although the described models do not completely replicate the physiopathological circumstances involved in the development of aneurysms in terms of hemodynamics, they proved to be equivalent to the condition observed in humans. Accordingly, it was appropriate for medical professionals to practice different endovascular procedures as well as useful for researchers to explore new therapeutic options5.

Although current treatments for myocardial infarction (MI) can reduce early mortality, a significant proportion of patients develop progressive heart failure. Martínez-Falguera et al. describe an MI model obtained by permanent coil deployment in swine that may be beneficial in exploring new therapeutic options6. The described method is proven to be feasible and highly reproducible. It avoids the need for open-heart procedures and the accompanying inflammatory reaction that takes place after surgery. An important advantage is that this model reproduces the pathogenesis of non-revascularized MI found in humans and it is appropriate for MI models in their acute, sub-acute and even chronic phase, depending on the follow-up duration of a given study6.

When studying MI, or other cardiac conditions, post-mortem gross examination of the heart is complex and may be associated with several approach-related or interpretation errors. For that reason, standardized gross examination and sample harvesting protocols are crucial to guarantee the comparability, reproducibility, and success of experimental studies of CVDs carried out in large animal models. Constantin and Tăbăran demonstarte two standard gross examination protocols (inflow-outflow and four-chamber dissection methods), pointing out the gross examination methods and the sampling sites routinely employed for histopathologic analysis that can be adapted to any species7. The presented protocol could serve as a guideline for cardiac dissection, which can easily be used in investigations requiring an exhaustive heart evaluation7.

Transcatheter pulmonary valve replacement is increasingly common in patients with congenital heart disease, acquired dysfunction of the right ventricular outflow tract, or of a bioprosthetic valve. Although early and late results in the clinical scenario are satisfying, there are numerous clinical challenges that must be taken into account for lifetime employment, especially in young people. The study presented by Hao et al. shows the feasibility and long-term safety of a newly developed pulmonary valve8. The authors use the pericardium to engineer an autologous pulmonary valve that is then implanted at the native pulmonary valve location by means of a self-expandable Nitinol stent via catheterization of the jugular vein in a sheep model. While the study has certain limitations, such as the sample size used, it constitutes a considerable advancement for safe and efficient implementation for upcoming preclinical trials as well as translation to the clinical setting.

Atrial fibrillation (AF) is the most extensive cardiac arrhythmia attributable to structural atrial myopathy, defined as structural remodeling of the atria. The discovery of new treatment approaches requires the development of reproducible large animal models of atrial myopathy. Most currently available models rely on atrial tachypacing, which reproduces conduction disorders but in the absence of structural changes that normally precede electrical changes. To meet this requirement, Tubeeckx et al. describe a clinically relevant porcine atrial myopathy model induced by sterile pericarditis, showing inducibility of AF as well as rapid development of inflammation and fibrosis. Presenting previously described features, this large animal model could help explore new strategies for the treatment of atrial myopathy and AF9.

In recent years, we have seen impressive advances in the management of CVDs, allowing for mechanistic insights and new therapeutic approaches. While the number of animals employed for research and training purposes must decrease in accordance to current ethical considerations and studies involving animal models must be optimized taking animal welfare into consideration10, experimental animals cannot entirely be replaced by other systems. Large animal models will remain the best tool for advancing the understanding of mechanisms of human CVDs11, since the use of human-like settings increases the chances of bench findings translating to effective treatments4. A platform representative of the complex biological interactions present in clinical diseases is a requirement to further advance the understanding of these highly prevalent conditions. As such, the large animal models described in this methods collection could help bridge the gap from the bench to the bedside, contributing to the knowledge of disease pathogenesis and representing essential tools to develop diagnostic techniques and therapeutic strategies. This comprehensive methods collection ranges from cerebrovascular diseases to structural, rhythmic and ischemic heart disease, up to the all-important sampling techniques necessary to obtain meaningful results. Moreover, these models allow physicians to practice challenging procedures in systems that are close to the human anatomy and enhance clinical approaches to several CVDs.


The authors have nothing to disclose.


We would like to thank all the authors for their excellent contributions to this collection. This research was funded by Agencia Estatal de Investigación (PID2019-107329RA-C22/AEI/10.13039/501100011033), Consejería de Economía, Ciencia y Agencia Digital, Junta de Extremadura (IB20191, GR18199), and Instituto de Salud Carlos III (PI20/00247, CB16/11/00494), cofounded by European Regional Development Fund “A way to make Europe”.


  1. Tsao, C. W., et al. Heart disease and stroke statistics—2022 update: A report from the American Heart Association. Circulation. 145 (8), 153 (2022).
  2. Spannbauer, A., et al. Large animal models of Heart Failure With Reduced Ejection Fraction (HFrEF). Frontiers in Cardiovascular Medicine. 6, 117 (2019).
  3. Dixon, J. A., Spinale, F. G. Large animal models of heart failure: a critical link in the translation of basic science to clinical practice. Circulation. Heart Failure. 2 (3), 262-271 (2009).
  4. Tsang, H. G., et al. Large animal models of cardiovascular disease. Cell Biochemistry and Function. 34 (3), 113-132 (2016).
  5. Blanco-Blázquez, V., et al. Swine models of aneurysmal diseases for training and research. Journal of Visualized Experiments. (181), e63616 (2022).
  6. Martínez-Falguera, D., et al. Myocardial infarction by percutaneous embolization coil deployment in a swine model. Journal of Visualized Experiments. (177), e63172 (2021).
  7. Constantin, I., Tăbăran, A. F. Dissection techniques and histological sampling of the heart in large animal models for cardiovascular diseases. Journal of Visualized Experiments. (184), e63809 (2022).
  8. Hao, Y., et al. Transcatheter pulmonary valve replacement from autologous pericardium with a self-expandable nitinol stent in an adult sheep model. Journal of Visualized Experiments. (184), e63661 (2022).
  9. Tubeeckx, M. R. L., et al. Sterile pericarditis in aachener minipigs as a model for atrial myopathy and atrial fibrillation. Journal of Visualized Experiments. (175), e63094 (2021).
  10. Ribitsch, I., et al. Large animal models in regenerative medicine and tissue engineering: To do or not to do. Frontiers in Bioengineering and Biotechnology. 8, 972 (2020).
  11. Zaragoza, C., et al. Animal models of cardiovascular diseases. Journal of Biomedicine and Biotechnology. 2011, 497841 (2011).

Cite this Article

Báez-Díaz, C., Crisóstomo, V. Large Animal Models of Cardiovascular Disease: From Training to Translation. J. Vis. Exp. (193), e64983, doi:10.3791/64983 (2023).More

Báez-Díaz, C., Crisóstomo, V. Large Animal Models of Cardiovascular Disease: From Training to Translation. J. Vis. Exp. (193), e64983, doi:10.3791/64983 (2023).

Copy Citation Download Citation Reprints and Permissions
View Video

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter